- Clinical Trials
- April 2025
- 60 Pages
Global
From €1832EUR$2,000USD£1,557GBP
- Report
- February 2025
- 222 Pages
Global
From €2290EUR$2,500USD£1,946GBP
- Report
- June 2024
- 200 Pages
Global
From €7283EUR$7,950USD£6,190GBP
- Report
- May 2024
- 137 Pages
Global
From €5953EUR$6,499USD£5,060GBP
- Report
- January 2022
- 60 Pages
Global
From €3618EUR$3,950USD£3,075GBP
The Skin Disease Drugs market is a subset of the Dermatological Drugs market, which includes drugs used to treat skin diseases and conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Common treatments include topical creams, ointments, and oral medications. Many of these drugs are available over-the-counter, while others require a prescription from a doctor.
The Skin Disease Drugs market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Pfizer, Novartis, Johnson & Johnson, and Merck. Other companies include Allergan, Sanofi, Bayer, and Mylan. Show Less Read more